The process of transcatheter arterial chemoembolization is characterized by the ability to
accurately deliver chemotherapy drugs with minimal systemic side effects and has become …

The aim of this standard operational procedure is to standardize the methodology employed
for the evaluation of pre-and post-treatment absorbed dose calculations in 90 Y microsphere …

For patients with unresectable colorectal liver metastases (uCRLM), regional therapies
leverage the unique, dual blood supply to the liver; the hepatic artery is the main blood …

Background There is an increasing body of evidence indicating Y90 dose thresholds for
tumor response and treatment-related toxicity. These thresholds are poorly studied in resin …

Purpose To compare the accuracy and safety of 0.56 GBq resin yttrium-90 (90 Y)(scout 90 Y)
microspheres with those of technetium-99m macroaggregated albumin (MAA) in predicting …

Background To improve therapy outcome of Yttrium-90 selective internal radiation therapy
(90 Y SIRT), patient-specific post-therapeutic dosimetry is required. For this purpose, various …

Transarterial radioembolization (TARE) with Yttrium-90 (Y90) is a growing area of study due
to its benefits in early-, intermediate-, and late-stage hepatocellular carcinoma. Treatment …

Purpose To perform precision dosimetry in yttrium-90 radioembolization through CT imaging
of radiopaque microspheres in a rabbit liver model and to compare extracted dose metrics to …

Uveal melanoma is one of the most common primary intraocular malignancies that accounts
for about 85% of all ocular melanomas. The pathophysiology of uveal melanoma is distinct …

Liver malignancy, including primary liver cancer and metastatic liver cancer, has become
one of the most common causes of cancer-related death worldwide due to the high …